Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cephalexin Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | SLC15A2 | Q16348 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 0.85 |
| ▸ | LMNA | P02545 | 2/20 | 0.85 |
| ▸ | ESR1 | P03372 | 1/20 | 0.85 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.85 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cephalexin Anhydrous SCHEMBL8467348 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL12961263 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL11985597 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL11579781 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL6663551 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL10713860 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL6663545 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL2961 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL20703090 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 | |
| Cephalexin Anhydrous SCHEMBL11569012 | 1.00 | HSD17B10 (1.00) | HSD17B10MAPTALDH1A1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3344325-A1 | LOCAL ADMINISTRATION OF DRUGS FOR THE TREATMENT OF ASTHMA | Mercator Medsystems, Inc. (US) | 2018-07-11 | — | — | EP | disclosed |
| WO-2017040605-A1 | LOCAL ADMINISTRATION OF DRUGS FOR THE TREATMENT OF ASTHMA | MERCATOR MEDSYSTEMS, INC. (US) | 2017-03-09 | — | — | WO | disclosed |
| EP-3086646-A2 | PLANTS CONTAINING BENEFICIAL ENDOPHYTES | Indigo AG, Inc. (US) | 2016-11-02 | — | — | EP | disclosed |
| US-20150211044-A1 | QUICK METHOD FOR DETECTING ENYZMES AND MICROORGANISMS | BIO-RAD EUROPE GMBH (CH) | 2015-07-30 | — | — | US | disclosed |
| WO-2015100431-A2 | PLANTS CONTAINING BENEFICIAL ENDOPHYTES | SYMBIOTA, INC. (US) | 2015-07-02 | — | — | WO | disclosed |
| US-9012167-B2 | Quick method for detecting enzymes and microorganisms | BIO-RAD INNOVATIONS (FR) | 2015-04-21 | — | — | US | disclosed |
| WO-2014028745-A2 | A SYSTEM FOR COMPOUNDING AND PACKAGING READY TO RECONSTITUTE DRUG POWDERS OF SOLUTIONS TO A SOLUTION OR TO A SUSPENSION OR TO AN INJECTABLE | ARCHON PHARMACEUTICAL CONSULTING LLC (US) | 2014-02-20 | — | — | WO | disclosed |
| US-20130089883-A1 | QUICK METHOD FOR DETECTING ENYZMES AND MICROORANISMS | BIO-RAD INNOVATIONS (FR) | 2013-04-11 | — | — | US | disclosed |
| EP-2538970-A1 | TREATMENT OR PREVENTION OF INFECTION | Oral Health Australia Pty Ltd (AU) | 2013-01-02 | — | — | EP | disclosed |
| EP-2534202-A1 | POLYMER COMPOSITION | Mitsubishi Chemical Europe GmbH (DE) | 2012-12-19 | — | — | EP | disclosed |
| EP-0878229-A2 | Process for removal of high-molecular compounds from a process stream | CHEMFERM V.O.F. (NL) | 1998-11-18 | — | — | EP | disclosed |
| EP-0869962-A1 | PROCESS FOR THE RECOVERY OF A BETA-LACTAM ANTIBIOTIC | CHEMFERM V.O.F. (NL) | 1998-10-14 | — | — | EP | disclosed |
| CN-1179779-A | Process for recovery of cephalexin | CHEMFERM VOF (NL) | 1998-04-22 | — | — | CN | disclosed |
| WO-1996023797-A1 | PROCESS FOR THE RECOVERY OF A β-LACTAM ANTIBIOTIC | CHEMFERM V.O.F. (NL) | 1996-08-08 | — | — | WO | disclosed |
| US-4965193-A | Using beta-lactamase ring-containing substrate whose amide bond is hydrolyzed in the presence of beta-lactamase | WASHINGTON RESEARCH FOUNDATION (US) | 1990-10-23 | — | — | US | disclosed |
| WO-1989003889-A1 | DETECTION OF MICROBIAL BETA-LACTAMASE | WASHINGTON RESEARCH FOUNDATION (US) | 1989-05-05 | — | — | WO | disclosed |
| US-4680390-A | CEPHALOSPORINS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-07-14 | — | — | US | disclosed |
| US-4520194-A | BACTERICIDES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-05-28 | — | — | US | disclosed |
| US-4510138-A | 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]cephalosporin derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-04-09 | — | — | US | disclosed |
| US-4278671-A | ANTIBIOTICS, BACTERICIDES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-07-14 | — | — | US | disclosed |